Anaphylaxis News

BOSTON — Patients who were taking lipid-lowering medications experienced more severe anaphylaxis after insect stings, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Children with anaphylaxis who received epinephrine before going to the ED were significantly less likely to be admitted to the ICU, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is associated with a risk for anaphylaxis and issued a new boxed warning, according to a drug safety communication.

The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions manufactured by BPI Labs LLC and Endo USA.

Epinephrine autoinjector administration competence varied among caregivers, indicating a need for better education, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Symptomology varies among adults with anaphylaxis depending on the trigger, according to a study published in International Archives of Allergy and Immunology.

This year brought breakthroughs and important advances in asthma and allergy. Healio’s most popular stories in 2024 covered the long-anticipated approval of neffy epinephrine nasal spray and an update to anaphylaxis practice parameters.

A New York State Assemblymember celebrated the signing of two of her new bills into law that aim to expand epinephrine autoinjector accessibility across the state.

Healio has compiled November’s most read news in asthma and allergy.